BCL7A antibody (AA 40-120)

Catalog No. ABIN7224034

This Rabbit Polyclonal antibody specifically detects BCL7A in WB and ELISA. It exhibits reactivity toward Human and Mouse.

Quick Overview for BCL7A antibody (AA 40-120) (ABIN7224034)

Target: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BCL7A antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Product Details anti-BCL7A Antibody

Binding Specificity: AA 40-120

Purpose: Bcl-7a Polyclonal Antibody

Specificity: Bcl-7a Polyclonal Antibody detects endogenous levels of Bcl-7a protein.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Immunogen: Synthesized peptide derived from the Internal region of human Bcl-7a at AA range: 40-120

Isotype: IgG

Application Details

Application Notes: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000). Not yet tested in other applications.

Comment:

Primary Antibody

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Target Details for BCL7A

Target: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Alternative Name: Bcl-7a

Background: Rabbit Anti-Bcl-7a Polyclonal Antibody,BCL7A, B-cell CLL/lymphoma 7 protein family member A,BCL7A (BCL tumor suppressor 7A) is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for BCL7A.,B-cell CLL

Gene ID: 605

UniProt: Q4VC05